Ilkka Kangasniemi

Finnvera Oyj is a financing company that provides financing for the start-up, growth, and internationalization of enterprises and for protection against export risks. Its products include loans, domestic guarantees, export credit guarantees, venture capital investments, export credits, and interest equalization. The company was founded on July 9, 1998 and is headquartered in Kuopio, Finland.

Fortel Invest Oy (Fortel Invest) is a private equity subsidiary of Sipila Family founded in 1995 by Juha Sipila. The firm is headquartered in Oulu, Finland.

Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland.

Onbone Oy develops medical casting and splinting materials for use in the fields of orthopaedics, traumatology and occupational therapy. The company was founded by Petro Antero Kirmo Lahtinen, Antti Pärssinen, Jari Juhani Salo, Matti Eino Olavi Vaheri, and Karri Airola on November 18, 2008 and is headquartered in Oulu, Finland.

Flextronics Holding Finland Oy provides electrical engineering design services. The company was founded on June 1, 1999 and is headquartered in Helsinki, Finland.

Vitabalans Oy operates as a pharmaceutical firm. It offers painkillers, antibiotics, antidepressants, heart medicines, hypnotics, wound treatment, intimate care, and vitamins. The company was founded in 1980 and is headquartered in Hameenlinna, Finland.

Part of Corbion NV, Purac Biochem BV develops and manufactures food preservatives, biobased chemicals, and bioplastics. The company is based in Gorinchem, Netherlands.

Pelion (Finland) Oy develops software technology for the Internet of things. The company was founded by Mikko Johannes Saarnivala and Zach Shelby on December 23, 2015 and is headquartered in Oulu, Finland.

Oulun Seudun Hyvinvointirahasto Ky is a regional venture capital fund that invests in companies located in Oulu and Kainuu districts in Northern Ostrobothnia, Finland. It focuses on seed and early stage companies which have significant growth potential and which preferably operate in sectors such as health and biotechnology, internet services, and environment. It can also participate in later stage venture rounds and co-invest with other investors. The fund makes minority investments, the initial investment being EUR 75,000-400,000. It doesn't make new investments anymore but focuses on follow-up investments and developing existing portfolio companies.

Labrox Oy develops equipment and software for sample analysis in laboratories. Its products include multimode and single mode plate reader platforms, detection systems, modules, and components. The firm serves the pharmaceutical, food, and agriculture industries. The company was founded by Ida Karoliina Erling, Pauli Yrj? Tapani Salmelainen, Jarkko Sarmaala, Jukka Valtonen, Markku Ojala, and Antero Markku Juhani Yli-Koski in March 2011 and is headquartered in Turku, Finland.

Part of University of Turku, Turku University Hospital is a hospital that provides general medical and surgical services and other hospital services. The company is based in Turku, Finland.

Inspector Sec Oy provides construction services. The private company is based in Oulu, Finland.

Rescomi Oy provides computer programming services. The private company is based in Oulu, Finland.

Bio Bones Oy provides mechanical engineering services. The private company is based in Oulu, Finland.

Rebio Technologies Ltd. operates as a biotechnology company. It provides medical products. The company was founded in January 14, 2014 and is headquartered in Cranleigh, the United Kingdom.

Aucor Oy operates as a digital media agency. Its offer includes web design, web development, and web hosting. The company was founded on June 25, 2008 and is headquartered in Turku, Finland.

BonAlive Biomaterials Oy is a holding company that provides solutions to heal patients with bone defects. It develops synthetic biomaterial solutions for the treatment of chronically infected bone. Their products include BonAlive granules and BonAlive putty, which are osteostimulative; BonAlive granules, which inhibits bacterial growth and act as tool for bone cavity filling in the treatment of chronic osteomyelitis; and BonAlive plates, which have been designed for repair of orbital floor trauma. The company was founded by Fredrik Viktor Ollila on November 13, 2009 and is headquartered in Turku, Finland.